Management

Jane Homan
Co-Founder, EigenBio, LLC

Dr. Homan
is a Co-Founder of EigenBio, LLC as well as a co-founder of ioGenetics, LLC and a Director of ioGenetics, Inc., a company spun out to develop a portfolio of anti-infective biotherapeutics. She has established the intellectual property portfolio underpinning the current offerings. Dr. Homan is a veterinary epidemiologist and microbiologist who came to the biotechnology sector after 20 years international, research and administrative prior experience in academia. Formerly CEO and Co-Founder of Gala Biotech Inc. (subsequently sold to Cardinal Health and now part of Catalent Inc). Homan received a PhD in virology and veterinary science from University of Wisconsin-Madison, a Master’s degree in microbiology from the University of Saskatchewan. She is a Member of the Royal College of Veterinary Surgeons, having graduated from Glasgow University Veterinary School.



Robert Bremel
Co-Founder, EigenBio, LLC

Dr. Bremel is a Co-Founder of EigenBio, LLC as well as a co-founder of ioGenetics, LLC. As Chief Scientific Officer of ioGenetics, LLC, he has been a key inventor in the development of a broad patent portfolio. Formerly CEO and Co-Founder of Gala Biotech Inc. (subsequently sold to Cardinal Health and now part of Catalent Inc) and inventor of the GPex® technology. Dr. Bremel is a protein chemist and physiologist with a long track record in computer program development. He is an Emeritus Professor of the University of Wisconsin-Madison. Dr. Bremel earned his PhD in biochemistry from St Louis University and a BS in dairy science from the University of Wisconsin-Madison.